These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16007227)
1. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Sun Y; Lowther W; Kato K; Bianco C; Kenney N; Strizzi L; Raafat D; Hirota M; Khan NI; Bargo S; Jones B; Salomon D; Callahan R Oncogene; 2005 Aug; 24(34):5365-74. PubMed ID: 16007227 [TBL] [Abstract][Full Text] [Related]
2. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. Blokzijl A; Dahlqvist C; Reissmann E; Falk A; Moliner A; Lendahl U; Ibáñez CF J Cell Biol; 2003 Nov; 163(4):723-8. PubMed ID: 14638857 [TBL] [Abstract][Full Text] [Related]
3. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666 [TBL] [Abstract][Full Text] [Related]
4. Cited2 modulates TGF-beta-mediated upregulation of MMP9. Chou YT; Wang H; Chen Y; Danielpour D; Yang YC Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037 [TBL] [Abstract][Full Text] [Related]
5. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells. Gajewska M; Motyl T Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067 [TBL] [Abstract][Full Text] [Related]
6. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner. Pendaries V; Verrecchia F; Michel S; Mauviel A Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262 [TBL] [Abstract][Full Text] [Related]
7. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Kuang C; Chen Y Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP. Cui Q; Lim SK; Zhao B; Hoffmann FM Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622 [TBL] [Abstract][Full Text] [Related]
9. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662 [TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Xu G; Chakraborty C; Lala PK Biochem Biophys Res Commun; 2001 Sep; 287(1):47-55. PubMed ID: 11549251 [TBL] [Abstract][Full Text] [Related]
11. Burn injury induces an inhibitory signal in the lung Smad pathway. Pham TN; Cho K; Adamson LK; Hakimbashi M; Yang L; Tredget EE; Greenhalgh DG Cytokine; 2004 Jul 21-Aug 7; 27(2-3):66-73. PubMed ID: 15242695 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Cheng PL; Chang MH; Chao CH; Lee YH Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054 [TBL] [Abstract][Full Text] [Related]
13. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling. Imoto S; Sugiyama K; Sekine Y; Matsuda T FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489 [TBL] [Abstract][Full Text] [Related]
14. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821 [TBL] [Abstract][Full Text] [Related]
15. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells. Edmiston JS; Yeudall WA; Chung TD; Lebman DA Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298 [TBL] [Abstract][Full Text] [Related]